Overview

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the TCRN is to accelerate research in the management of thalassemia, standardize existing treatments, and evaluate new ones in a network of clinical centers in North America. The emphasis will be on clinical trials that help identify optimal therapy. Therapeutic trials may involve investigational drugs, drugs already approved but not currently used, and drugs currently used.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
HealthCore-NERI
New England Research Institutes
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
Thalassemia Clinical Research Network
Treatments:
Decitabine
Deferiprone
Deferoxamine
Sildenafil Citrate
Criteria
Please refer to specific studies for eligibility criteria.